GlassScriptPhysician profile
Kelley J Halstead
NPI 1063420552
$1,212.98
in general payments reported to CMS, 2019-2025
17 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $291 · 2021: $78.02 · 2022: $78.07 · 2023: $73.41 · 2024: $215 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.68 | 2019-2023 | |
| Lupin INC. | $230.24 | 2019-2020 | |
| Evofem Biosciences, INC. | $154.37 | 2021-2025 | Phexxi, Solosec, Phexx |
| Becton, Dickinson and Company | $100.77 | 2024 | Arista Ah Flexitip |
| Avion Pharmaceuticals | $85.22 | 2019-2020 | |
| Exeltis, USA INC. | $75.88 | 2020-2022 | |
| Therapeuticsmd, INC. | $49.66 | 2019-2022 | |
| Biogen, INC. | $49.07 | 2025 | Zurzuvae |
| Allergan, INC. | $44.84 | 2019 | |
| Mayne Pharma Commercial LLC | $42.05 | 2023-2025 | |
| Hologic Sales and Service, LLC | $32.62 | 2021-2024 | Aptima |
| Organon LLC | $28.52 | 2022-2025 | Jada System, Nexplanon |
| Astellas Pharma US INC | $24.87 | 2023 | Veozah |
| Vertical Pharmaceuticals, LLC | $18.18 | 2019 | |
| Shield Therapeutics INC | $17.34 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.76 | 2019 | |
| Merck Sharp & Dohme LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Halstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.